Meta-analysis of the correlation between glioma prognosis and PD-1/ PD-L1 expression

被引：0
|
作者：
Ren, Chang-cheng [1 ]
Xu, Bo [1 ]
Wang, Min-shu [1 ]
He, Feng [1 ]
Chen, Jun-hui [1 ]
Liao, Liang [1 ]
Liang, Wu [1 ]
机构：
[1] Hubei Minzu Univ, Dept Neurosurg, Minda Hosp, Enshi 445000, Peoples R China
来源：
ASIAN JOURNAL OF SURGERY | 2023年 / 46卷 / 12期
关键词：
Glioma; Prognosis; PD-1; PD-L1;
D O I：
10.1016/j.asjsur.2023.08.057
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：5632 / 5634
页数：3
相关论文
共 50 条
  • [31] Programmed Cell Death 1 (PD-1) Ligand (PD-L1) Expression in Solid Tumors As a Predictive Biomarker of Benefit From PD-1/PD-L1 Axis Inhibitors: A Systematic Review and Meta-Analysis
    Khunger, Monica
    Hernandez, Adrian V.
    Pasupuleti, Vinay
    Rakshit, Sagar
    Pennell, Nathan A.
    Stevenson, James
    Mukhopadhyay, Sanjay
    Schalper, Kurt
    Velcheti, Vamsidhar
    JCO PRECISION ONCOLOGY, 2017, 1 : 1 - 15
  • [32] Prognostic Significance of Programmed Cell Death 1 (PD-1) or PD-1 Ligand 1 (PD-L1) Expression in Epithelial-Originated Cancer A Meta-Analysis
    Zhang, Yaxiong
    Kang, Shiyang
    Shen, Jianfei
    He, Jiaxi
    Jiang, Long
    Wang, Wei
    Guo, Zhihua
    Peng, Guilin
    Chen, Gang
    He, Jianxing
    Liang, Wenhua
    MEDICINE, 2015, 94 (06) : e515
  • [33] Expression of PD-L1 and PD-1 in Cutaneous Warts
    Yu, Wesley
    Berger, Timothy
    Laszik, G. Zoltan
    North, Jeffrey
    Cohen, Jarish
    MODERN PATHOLOGY, 2019, 32
  • [34] PD-1/PD-L1 axis is involved in the interaction between microglial polarization and glioma
    Wang, Xi-Peng
    Guo, Wei
    Chen, Ye-Fan
    Hong, Chen
    Ji, Juan
    Zhang, Xi-Yue
    Dong, Yin-Feng
    Sun, Xiu-Lan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 133
  • [35] PD-L1 expression as biomarker of efficacy of PD-1/PD-L1 checkpoint inhibitors in metastatic triple negative breast cancer: A systematic review and meta-analysis
    Khan, Muhammad
    Du, Kunpeng
    Ai, Meiling
    Wang, Baiyao
    Lin, Jie
    Ren, Anbang
    Chen, Chengcong
    Huang, Zhong
    Qiu, Wenze
    Yuan, Yawei
    Tian, Yunhong
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [36] The Positive Expression of PD-L1/PD-1 in Gastroenteropancreatic Neuroendocrine Neoplasias Correlates with Prognosis
    Yinying, W.
    Chuying, W.
    NEUROENDOCRINOLOGY, 2017, 105 : 141 - 141
  • [37] PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups
    Schmidt, Lars Henning
    Kuemmel, Andreas
    Goerlich, Dennis
    Mohr, Michael
    Broeckling, Sebastian
    Mikesch, Jan Henrik
    Gruenewald, Inga
    Marra, Alessandro
    Schultheis, Anne M.
    Wardelmann, Eva
    Mueller-Tidow, Carsten
    Spieker, Tilmann
    Schliemann, Christoph
    Berdel, Wolfgang E.
    Wiewrodt, Rainer
    Hartmann, Wolfgang
    PLOS ONE, 2015, 10 (08):
  • [38] Expression of PD-L1 is associated with poor prognosis in breast cancer: A meta-analysis
    Zhang, M.
    ANNALS OF ONCOLOGY, 2016, 27
  • [39] Correlation between PD-L1 expression and PD-1 immune checkpoint blockade: A retrospective analysis for advanced melanoma.
    Cho, Jinhyun
    Ahn, Soomin
    Yoo, Kwai Han
    Song, Haa-Na
    Jung, Ki Sun
    Jang, Kee-Taek
    Lee, Jeeyun
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [40] Highly Activated PD-1/PD-L1 Pathway in Gastric Cancer with PD-L1 Expression
    Saito, Hiroaki
    Kono, Yusuke
    Murakami, Yuki
    Shishido, Yuji
    Kuroda, Hirohiko
    Matsunaga, Tomoyuki
    Fukumoto, Yoji
    Osaki, Tomohiro
    Ashida, Keigo
    Fujiwara, Yoshiyuki
    ANTICANCER RESEARCH, 2018, 38 (01) : 107 - 112
12345